29 March 2022: The annual general meeting of Aker BioMarine ASA will be held on Wednesday, 20 April 2022 at 15:00 CET. The proposed agenda includes the election of the new auditor.
The meeting will be conducted as a virtual meeting only, accessible online via Lumi AGM. For further information regarding participation, please refer to the guide available at www.akerbiomarine/agm.
No pre-registration is needed for attending online, but attendees must be logged in before the meeting starts. Deadline for registration of advance votes and proxies is 19 April 2022 at 16:00 CET.
Please find attached the following documents:
- Notice for the Annual General Meeting 2022
- Annual Report 2021 (including ESG report)
- Recommendation on selection of auditor
- Policy on Remuneration to the Executive Management
- Management remuneration report 2021
- Proposal from the Nomination Committee
All documents to be processed in the meeting are also available on www.akerbiomarine/agm.
For further information, please contact
Carl Christian Bachke, Investor Relations
Mobile: +47 909 808 48
Email: carl.bachke@akerbiomarine.com
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act.
About Aker BioMarine
Aker BioMarine is a leading biotech innovator and Antarctic krill-harvesting company developing krill-derived products for pharma, consumer health and wellness as well as animal nutrition. The company has a strong position in its industry and is the world's leading supplier of krill, the natural, powerful and health promoting source of nutrients from the pristine waters of Antarctica. Aker BioMarine is listed on Oslo Stock Exchange (AKBM). More information is available at www.akerbiomarine.com.